Expert Answers to HCP Questions on Androgen Deprivation Therapy for Prostate Cancer

Listen to experts answer audience questions from a live CCO webinar focused on current clinical guidance and key data on the optimal use of GnRH agonists and antagonists, androgen receptor inhibitors, and other treatments for nonmetastatic or metastatic prostate cancer.